DICE
Tema Trading & Prediction Markets ETF
Set alert
- YTD
- -14.37%
- 1 year
- -14.37%
- Open
- 22.64
- Prev close
- 22.48
- Mkt cap
- 2.27B
- Vol
- 2.13K
- Avg vol
- 2.40K
- EPS
- 1.48
- P/E
- 14.58
- Div yield
- 0.00%
More statistics
- Low
- 21.49
- High
- 22.64
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 8, 2023
- 50-d avg
- 25.00
- 200-d avg
- 25.00
- 1y target
- 0.00
News
2 weeks ago etftrends.com
Novel ETFs: New Milestones for Crypto, Leverage, & Sports
ETF issuers continue to push the boundaries of product innovation and unconventional strategies attract greater attention, as regulators consider the next wave of novel ETFs outlined in my previous…
1 month ago benzinga.com
Anthropic, Kalshi and Polymarket Before Their IPOs? ETFs Are Finding a Way in
Tema ETFs is offering pre-IPO exposure to Anthropic, Kalshi and Polymarket through ETFs, using SPVs to access private-market names.
1 month ago etftrends.com
Novel ETFs: New Strategies Push Boundaries
As ETF strategies continue to expand into new asset classes and structures, the SEC has been taking a closer look at how some of these products fit within existing regulations.
3 years ago prnewswire.com
Lilly Completes Acquisition of DICE Therapeutics
INDIANAPOLIS , Aug. 9, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of DICE Therapeutics, Inc. (NASDAQ: DICE). The acquisition…
3 years ago prnewswire.com
Lilly Announces Extension of Tender Offer to Acquire DICE
INDIANAPOLIS , July 25, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares…
3 years ago marketwatch.com
Drugmakers' deal making will plow ahead despite antitrust scrutiny, analysts say
The brisk pace of biopharmaceutical deal making seen in the first half of this year may only accelerate in the months ahead, even as regulators take a hard look at some of the bigger deals, analysts…
3 years ago businesswire.com
DICE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of DICE…
-
3 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
3 years ago zacks.com
DICE Therapeutics (DICE) Up 37% on Buyout Offer from Eli Lilly
DICE Therapeutics (DICE) is set to be acquired by pharma-giant Eli Lilly (LLY) in an all-cash transaction for $2.4 billion. The transaction will likely close by third-quarter 2023.
3 years ago zacks.com
ETFs to Capitalize on Eli Lilly's Buyout of DICE Therapeutics
Eli Lilly (LLY) has agreed to acquire DICE Therapeutics (DICE) in a cash deal worth approximately $2.4 billion. This strategic move is part of Eli Lilly's efforts to bolster its immunology pipeline,…
3 years ago proactiveinvestors.com
Eli Lilly takeover of DICE Therapeutics ‘makes strategic sense,' says broker
Eli Lilly and Co (NYSE:LLY)'s $2.4 billion acquisition of DICE Therapeutics “makes strategic sense,” bolstering the global pharmaceutical company's presence in immunology, analysts at UBS said in a…
3 years ago fool.com
Is Eli Lilly's Dice Therapeutics Acquisition a Needle-Moving Event?
Eli Lilly and Dice Therapeutics agreed to a $2.4 billion buyout on Tuesday. Lilly might have landed important new immunology drugs via this deal.
3 years ago businesswire.com
DICE THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of DICE…
-
3 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2023
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2023
3 years ago fool.com
Eli Lilly's $2.4 Billion Acquisition of Dice Therapeutics: What Investors Need to Know
Lilly plans to buy Dice Therapeutics for $2.4 billion to expand its immunology pipeline. Investors appear to approve of the deal's price tag.
-
3 years ago benzinga.com
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares gained 79.5% to $0.2740.
3 years ago gurufocus.com
Shares of Eli Lilly, Dice Therapeutics Gain on Acquisition Announcement
Looking to enhance its product portfolio for immune-related diseases, an area where it has lagged behind the competition, Eli Lilly & Co. ( LLY , Financial) announced on Tuesday it is acquiring Dice…
3 years ago investopedia.com
Eli Lilly Buys DICE Therapeutics for $2.4 Billion
Eli Lilly agreed to buy DICE Therapeutics for $2.4 billion. The deal values DICE shares at an almost 40% premium from Friday's close.
3 years ago investopedia.com
Markets Fall at Midday, Pulled Lower by Energy Stocks
Markets opened the shortened trading week on Tuesday, June 20, 2023 with losses as oil stocks sank along with the price of crude.
3 years ago fool.com
Why Shares of Dice Therapeutics Are Skyrocketing Tuesday
Lilly is paying a 40% premium for Dice's shares. Dice is a clinical-stage biotech with six programs in its pipeline.
3 years ago stockmarket.com
2 Biotech Stocks For Your June 2023 Watchlist
Biotech stocks to watch in the stock market now.
3 years ago schaeffersresearch.com
Options Traders Blast Dice Therapeutics Stock After Buyout
Dice Therapeutics Inc (NASDAQ:DICE) was last seen up 37.6% to trade at a fresh all-time high of $46.56, after Eli Lilly (LLY) revealed it will buy the immunology drug maker for roughly $2.4 billion ,…
-
3 years ago benzinga.com
US Stocks Mixed; Housing Starts Surge In May
U.S. stocks traded mixed this morning, with Dow Jones dropping over 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.52% to 34,120.19 while the NASDAQ rose 0.15% to…
3 years ago investorplace.com
Why Is Dice Therapeutics (DICE) Stock Up 38% Today?
Dice Therapeutics (NASDAQ: DICE ) stock is surging higher on Tuesday after Eli Lilly (NYSE: LLY ) announced plans to acquire the biopharmaceutical company. According to a news release, Eli Lilly is…
3 years ago proactiveinvestors.com
Eli Lilly sends DICE Therapeutics' shares soaring with $2.4B takeover
Eli Lilly and Co (NYSE:LLY) said it has signed a definitive agreement to acquire DICE Therapeutics for $2.4 billion, sending shares of the biopharmaceutical company higher in pre-market trade. Under…
-
3 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
-
3 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
-
4 years ago benzinga.com
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.
-
4 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low…
-
4 years ago benzinga.com
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 951 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning trading, 400 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 615 stocks hit new 52-week lows.
-
5 years ago benzinga.com
48 Biggest Movers From Yesterday
Gainers Xiaobai Maimai Inc. (NASDAQ: HX) shares surged 98.4% to settle at $18.87 on Wednesday on above-average volume. The company on Tuesday disclosed the resignation of its CEO and Chairman and…
-
5 years ago benzinga.com
36 Biggest Movers From Yesterday
Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares climbed 36.4% to settle at $10.35 on Tuesday amid an increase in the price of Bitcoin and Ethereum.
-
5 years ago benzinga.com
53 Biggest Movers From Yesterday
Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share.